191 related articles for article (PubMed ID: 20855747)
21. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.
Beyda ND; Lewis RE; Garey KW
Ann Pharmacother; 2012; 46(7-8):1086-96. PubMed ID: 22811350
[TBL] [Abstract][Full Text] [Related]
22. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
Antimicrob Agents Chemother; 2008 Jan; 52(1):321-8. PubMed ID: 17938191
[TBL] [Abstract][Full Text] [Related]
23. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.
Garcia-Effron G; Katiyar SK; Park S; Edlind TD; Perlin DS
Antimicrob Agents Chemother; 2008 Jul; 52(7):2305-12. PubMed ID: 18443110
[TBL] [Abstract][Full Text] [Related]
24. Aspergillus fumigatus devoid of cell wall β-1,3-glucan is viable, massively sheds galactomannan and is killed by septum formation inhibitors.
Dichtl K; Samantaray S; Aimanianda V; Zhu Z; Prévost MC; Latgé JP; Ebel F; Wagener J
Mol Microbiol; 2015 Feb; 95(3):458-71. PubMed ID: 25425041
[TBL] [Abstract][Full Text] [Related]
25. Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.
Meletiadis J; Siopi M; Kanioura L; Jørgensen KM; Perlin DS; Mouton JW; Arendrup MC
J Antimicrob Chemother; 2019 Aug; 74(8):2247-2254. PubMed ID: 31106352
[TBL] [Abstract][Full Text] [Related]
26. Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008).
Messer SA; Jones RN; Moet GJ; Kirby JT; Castanheira M
J Clin Microbiol; 2010 Aug; 48(8):2984-7. PubMed ID: 20534798
[TBL] [Abstract][Full Text] [Related]
27. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
[TBL] [Abstract][Full Text] [Related]
28. Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.
Arendrup MC; Perkhofer S; Howard SJ; Garcia-Effron G; Vishukumar A; Perlin D; Lass-Flörl C
Antimicrob Agents Chemother; 2008 Oct; 52(10):3504-11. PubMed ID: 18644959
[TBL] [Abstract][Full Text] [Related]
29. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
30. Echinocandin resistance in human pathogenic fungi.
Munro CA
Expert Rev Anti Infect Ther; 2012 Feb; 10(2):115-6. PubMed ID: 22339184
[No Abstract] [Full Text] [Related]
31. Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
Wiederhold NP; Locke JB; Daruwala P; Bartizal K
J Antimicrob Chemother; 2018 Nov; 73(11):3063-3067. PubMed ID: 30032217
[TBL] [Abstract][Full Text] [Related]
32. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin.
Imtiaz T; Lee KK; Munro CA; MacCallum DM; Shankland GS; Johnson EM; MacGregor MS; Bal AM
J Med Microbiol; 2012 Sep; 61(Pt 9):1330-1334. PubMed ID: 22653922
[TBL] [Abstract][Full Text] [Related]
33. Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point-Mutation-Mediated Resistance.
Jospe-Kaufman M; Ben-Zeev E; Mottola A; Dukhovny A; Berman J; Carmeli S; Fridman M
Angew Chem Int Ed Engl; 2024 Feb; 63(9):e202314728. PubMed ID: 38161189
[TBL] [Abstract][Full Text] [Related]
34. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713
[TBL] [Abstract][Full Text] [Related]
35. Interaction of platelets and anidulafungin against Aspergillus fumigatus.
Perkhofer S; Striessnig B; Sartori B; Hausott B; Ott HW; Lass-Flörl C
Antimicrob Agents Chemother; 2013 Jan; 57(1):626-8. PubMed ID: 23114752
[TBL] [Abstract][Full Text] [Related]
36. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.
Martos AI; Martín-Mazuelos E; Romero A; Serrano C; González T; Almeida C; Puche B; Cantón E; Pemán J; Espinel-Ingroff A
Diagn Microbiol Infect Dis; 2012 May; 73(1):53-6. PubMed ID: 22480568
[TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2009 Oct; 47(10):3323-5. PubMed ID: 19710267
[TBL] [Abstract][Full Text] [Related]
39. Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae.
Katiyar SK; Edlind TD
Antimicrob Agents Chemother; 2009 May; 53(5):1772-8. PubMed ID: 19258277
[TBL] [Abstract][Full Text] [Related]
40. Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase.
Logviniuk D; Jaber QZ; Dobrovetsky R; Kozer N; Ksiezopolska E; Gabaldón T; Carmeli S; Fridman M
J Am Chem Soc; 2022 Apr; 144(13):5965-5975. PubMed ID: 35347986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
